Literature DB >> 18672145

Familial melanoma.

Johan Hansson1.   

Abstract

Approximately 5% to 10% of cases of cutaneous melanoma occur in families that have a hereditary predisposition for this disease. In 20% to 40% of such melanoma families, germline mutations in the CDKN2A gene have been identified. Apart from a high risk of melanoma, a proportion of kindreds that have familial melanoma also have an increased risk of pancreatic carcinoma. Guidelines for management of familial melanoma and the issue of genetic testing for CDKN2A germline mutations are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18672145     DOI: 10.1016/j.suc.2008.04.005

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  6 in total

1.  Topical application of bleaching phenols; in-vivo studies and mechanism of action relevant to melanoma treatment.

Authors:  Vidhya Hariharan; Timothy Toole; Jared Klarquist; Jeffrey Mosenson; B Jack Longley; I Caroline Le Poole
Journal:  Melanoma Res       Date:  2011-04       Impact factor: 3.599

Review 2.  An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies.

Authors:  Maria J Baker; Alisa M Goldstein; Patricia L Gordon; Kimberly S Harbaugh; Heath B Mackley; Michael J Glantz; Joseph J Drabick
Journal:  J Med Genet       Date:  2016-01-21       Impact factor: 6.318

Review 3.  Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma.

Authors:  James V Tricoli; Donald G Blair; Carey K Anders; W Archie Bleyer; Lisa A Boardman; Javed Khan; Shivaani Kummar; Brandon Hayes-Lattin; Stephen P Hunger; Melinda Merchant; Nita L Seibel; Magdalena Thurin; Cheryl L Willman
Journal:  Cancer       Date:  2016-02-05       Impact factor: 6.860

4.  Somatic BRAF and NRAS mutations in familial melanomas with known germline CDKN2A status: a GenoMEL study.

Authors:  Abdlsattar Zebary; Katarina Omholt; Remco van Doorn; Paola Ghiorzo; Katja Harbst; Carolina Hertzman Johansson; Veronica Höiom; Göran Jönsson; Dace Pjanova; Susana Puig; Giovanna B Scarra; Mark Harland; Håkan Olsson; Suzanne Egyhazi Brage; Jane Palmer; Lena Kanter-Lewensohn; Ismini Vassilaki; Nicholas K Hayward; Julia Newton-Bishop; Nelleke A Gruis; Johan Hansson
Journal:  J Invest Dermatol       Date:  2013-06-14       Impact factor: 8.551

5.  Hereditary melanoma: a five-year study of Brazilian patients in a cancer referral center - phenotypic characteristics of probands and pathological features of primary tumors.

Authors:  Bianca Costa Soares de Sá; Luciana Facure Moredo; Elimar Elias Gomes; Erica Sara Souza de Araújo; João Pedreira Duprat
Journal:  An Bras Dermatol       Date:  2018-06       Impact factor: 1.896

6.  Management of melanoma families.

Authors:  Wilma Bergman; Nelleke A Gruis
Journal:  Cancers (Basel)       Date:  2010-04-16       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.